GlaxoSmithKline's new shingles vaccine Shingrix quickly captured the market after winning FDA approval and a preferential recommendation from CDC vaccine advisers
Despite strong sales of shingles vaccine Shingrix,?GlaxoSmithKline?reported its?sales and earnings fell 2 percent?in the first quarter of the year, largely due to...